Nucleus Biologics

Custom cell media can be a complicated process. Here's how we make it simple: #cellculture #tcellmedia #celltherapy

How is #COVID19 affecting the cell and gene therapy industry? Read this insightful article from McKinsey https://hubs.ly/H0vbwkL0

Kite flies high with second CAR-T approval - Bioprocess Insider https://hubs.ly/H0thW7B0 #celltherapy

At Nucleus Biologics, we have a small, motivated and diverse team. Our company is majority female, our leadership team and board have gender and ethnic diversity, and we are thinking of ways we as a small business can make more of an impact.

ICYMI: We are excited to announce the launch of NB-Lux, the world's first instantaneous custom cGMP cell culture media configurator! Check it out! https://hubs.ly/H0rdNl80 #nblux #celltherapy #genetherapy #masscustomization

The team at Nucleus Biologics believes that systemic racism and discrimination have no place in our society. There is no doubt that black lives matter and we know that understanding, empathy, and action are the antithesis of hatred, fear, and bigotry. Nucleus Biologics has always maintained a culture of inclusivity and will continue building upon our foundation of equality, transparency and respect for one another. The time is now to come together and drive change. We are committed to having the challenging conversations to impact change, not only with our company, but within our communities. We are working on our plan of action and will continue to share our progress.

"No longer must a scientist guess what to add to proprietary, sole sourced media or wait almost half a year to receive custom media" https://hubs.ly/H0r2HLs0 #celltherapy #NBlux #genetherapy

This is the first step in our plan to reshape the #cellculture media market. https://hubs.ly/H0r0hM20 #celltherapy #NBLux #genetherapy

FDA names 28 antibody tests to be taken off the market #covid19 https://hubs.ly/H0qPyYW0

Pfizer's DMD #genetherapy looks good in data refresh, but safety concerns persist https://hubs.ly/H0qKJ9W0

COVID-19's Impact On Patient Centricity https://hubs.ly/H0pKttW0

Introducing our new #cGMP islet culturing solutions for improved in vitro #islet function and standardized processing. https://hubs.ly/H0n0J9Q0

Cancer cell therapy success grows, but hospitals struggle with cost https://hubs.ly/H0l6YxX0

EXCITING NEWS: Nucleus Biologics has acquired Primorigen Biosciences! This furthers our ability to provide traceable & reproducible #cellculture ecosystems for cell & #genetherapy. We look forward to offering you more #cell culture products https://hubs.ly/H0kmtCg0